- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04342260
Improving Quality of Life After Thoracic Surgery Using Patient-Reported Outcomes
January 22, 2024 updated by: UNC Lineberger Comprehensive Cancer Center
This study is designed to test if patient-reported outcomes with automated reporting to clinicians for remote monitoring of postoperative symptoms is feasible and improves quality of life, health outcomes, and service utilization in thoracic surgery patients.
Patients undergoing thoracic surgery will be asked to self-report symptoms for remote monitoring by their care team.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a single center, randomized feasibility study.
A total of 140 patients undergoing thoracic surgery will be prospectively enrolled and randomized in a 1:1 ratio to one of two arms.
All participants will complete patient-reported outcome (PRO) symptom monitoring.
The two arms are 1) active symptom monitoring and 2) passive symptom monitoring.
The participants randomized to active symptom monitoring will have alerts sent to their clinicians when their PRO symptom scores exceed baseline postoperative scores (when discharge day scores are available) by 2 points or more, or when 'severe' or 'very severe' symptoms are reported.
Participants randomized to the passive PRO monitoring arm will complete the same PROs as participants in the active monitoring arm, but will not have alerts sent to their clinician.
All participants will be administered survey instruments to assess quality of life, satisfaction, and health history.
In addition, a subset of 40 participants and their caregivers will be chosen at 2 months postoperatively to complete a semi-structured interview about their postoperative symptom reporting experience.
Study Type
Interventional
Enrollment (Actual)
113
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina at Chapel Hill
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
Patients -
- 18 years or older
- English speaking
- Able and willing to complete web-based symptom survey
- Be presenting for inpatient thoracic surgery
Caregivers -
- 18 years or older
- English speaking
- Be a caregiver for a patient who has undergone thoracic surgery and enrolled in the PRO portion of the study
Exclusion Criteria:
Patients -
- Not completing planned surgery within 3 months of obtaining informed consent
- Diagnosis of esophageal cancer
- Inability to read and speak English
- Presenting for a day surgery
- Presenting for foregut surgery (e.g. paraesophageal hernia repair)
- Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent.
- Current incarceration
- Pregnancy
Caregiver -
- Inability to read and speak English
- Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent.
- Current incarceration
- Not currently providing care for a patient who has undergone thoracic surgery and enrolled in the PRO portion of the study
- Receiving extensive medical treatment (e.g., caregivers admitted in the intensive care unit)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Active Monitoring
Clinicians will receive symptom alerts if the survey suggests increased or worsening symptoms.
|
The participants randomized to active symptom monitoring will have alerts sent to their clinicians when their PRO symptom scores exceed baseline postoperative scores (when discharge day scores are available) by 2 points or more, or when 'severe' or 'very severe' symptoms are reported.
|
Active Comparator: Passive Monitoring
Clinicians will not receive any symptom alerts.
|
Participants randomized to the passive PRO monitoring arm will complete the same PROs as participants in the active monitoring arm, but will not have alerts sent to their clinician.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life at 12 months
Time Frame: Baseline through 12 months post-discharge
|
Quality of Life (QOL) will be measured by the EORTC (European Organisation for Research and Treatment of Cancer) Quality of Life Questionnaire Core-30 (EORTC QLQ-C30) version 3.0 and reported as a score on a scale from 0 to 100 with a higher score being a better QOL.
|
Baseline through 12 months post-discharge
|
Lung cancer specific quality of life at 12 months
Time Frame: Baseline through 12 months post-discharge
|
Lung cancer specific Quality of Life will be measured by the EORTC (European Organisation for Research and Treatment of Cancer) Quality of Life Questionnaire Lung Cancer-13 (EORTC QLQ-LC13) supplement and reported as a score from 0 to 100 with a higher score being worse symptoms
|
Baseline through 12 months post-discharge
|
PRO symptom monitoring surveys completed at 3 months
Time Frame: Baseline through 3 months post-discharge
|
The percentage of complete symptom surveys out of delivered symptom surveys will be calculated.
|
Baseline through 3 months post-discharge
|
PRO symptom monitoring alerts resulting in a clinician response at 3 months
Time Frame: Baseline through 3 months post-discharge
|
The percentage of survey alerts that generate a clinician response will be calculated.
|
Baseline through 3 months post-discharge
|
Barriers and facilitators of PRO monitoring after thoracic surgery
Time Frame: 2 months through 2 years post-discharge
|
Semi-structured interviews of patients and caregivers will be analyzed for themes.
|
2 months through 2 years post-discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Readmission at 3 months
Time Frame: Baseline through 3 months post-discharge
|
Readmission will be compared between arms using Cox proportional hazards regression model.
|
Baseline through 3 months post-discharge
|
Overall Survival at 12 months
Time Frame: Baseline through 12 months post-discharge
|
Survival will be compared between arms using Cox proportional hazards regression model.
|
Baseline through 12 months post-discharge
|
Quality of life surveys completed at 2 years
Time Frame: Baseline through 2 years post-discharge
|
The percentage of complete quality of life surveys out of delivered quality of life surveys will be calculated.
The quality of life surveys consist of the EORTC QLQ-C30 and EORTC QLQ-LC13.
|
Baseline through 2 years post-discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Gita Mody, MD, MPH, University of North Carolina, Chapel Hill
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 30, 2020
Primary Completion (Actual)
November 10, 2023
Study Completion (Actual)
November 10, 2023
Study Registration Dates
First Submitted
March 24, 2020
First Submitted That Met QC Criteria
April 9, 2020
First Posted (Actual)
April 10, 2020
Study Record Updates
Last Update Posted (Actual)
January 23, 2024
Last Update Submitted That Met QC Criteria
January 22, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- LCCC1945
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No plans as of now to make IPD available to other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thoracic Surgery
-
Maquet Cardiopulmonary GmbHNAMSARecruitingCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedCardiac Surgery | Cardiopulmonary Bypass | Thoracic SurgeryNetherlands
-
Örebro University, SwedenRecruiting
-
Hospices Civils de LyonCompletedSurgery | ThoracicFrance
-
Hospital de Clinicas de Porto AlegreUNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL (UFRGS)Completed
-
Universidade Federal de PernambucoReal Hospital Português de Beneficência em PernambucoCompleted
-
Universidade Federal de PernambucoUnknown
-
Hopital FochCompleted
-
Assaf-Harofeh Medical CenterUnknownThoracic Surgery
Clinical Trials on Active Monitoring
-
Duke UniversityNational Cancer Institute (NCI)CompletedDuctal Carcinoma in SituUnited States
-
Alliance Foundation Trials, LLC.Patient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Washington... and other collaboratorsActive, not recruitingDuctal Carcinoma in Situ | DCISUnited States
-
University of PittsburghRANDCompletedAdverse Drug EventsUnited States
-
University College, LondonUniversity of Cambridge; Royal Brompton & Harefield NHS Foundation Trust; University...CompletedColorectal Cancer | Pulmonary MetastasesUnited Kingdom, China, Italy, Serbia
-
University of Southern CaliforniaCasa Colina Hospital and Centers for HealthcareRecruiting
-
Institute for Health Economics and Policy, JapanSenzoku Stress Coping Support OfficeRecruiting
-
Skidmore CollegePenn State UniversityCompleted
-
University of OxfordUniversity of BristolActive, not recruiting
-
University of Southern CaliforniaEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedInfarction | Stroke | Cerebrovascular Disorders | Brain IschemiaUnited States
-
Douglas Mental Health University InstituteMcGill University; National Institute on Aging (NIA); Montreal Neurological Institute...Recruiting